Therakind Ltd
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
With a track record of bringing three speciality products to market, Therakind is currently seeking co-development opportunities within its two focus areas: Intranasal dry powder drug development using its DriDose® delivery platform comprising both single and multi-dose devices, and a novel board spectrum antimicrobial candidate.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}